Memorial Sloan Kettering Cancer Center shared a post on LinkedIn about a recent article by Hely Ollila et al. published in JCO Precision Oncology:
“A new study from Memorial Sloan Kettering Cancer Center (MSK) is testing a long-held assumption about mesothelioma, a rare cancer that usually starts in the lining around the lungs. It has long been thought of as a condition that affects older men, especially those who may have been exposed to asbestos.
Researchers say they’ve become increasingly aware of patients with this aggressive cancer under the age of 50, including a surprising number of younger women with no self-reported potential exposures to asbestos.
‘Early detection and diagnosis are critical for survival,’ says MSK thoracic medical oncologist Dr. Michael Offin. ‘It’s also important that young patients with mesothelioma seek treatment at a comprehensive cancer center like MSK.’
‘The patient cases in this study should serve as a warning to the medical community that when a younger person comes in with complaints like persistent coughing, chest pain, and shortness of breath, mesothelioma should be considered, especially if the patient’s symptoms are not resolved with antibiotics,’ says study co-author and MSK thoracic surgeon Dr. Prasad Adusumilli.
Learn more about how MSK is treating younger patients with mesothelioma.”
Title: Diffuse Pleural Mesothelioma in Young (Age ≤50 Years) and Very Young (Age ≤35 Years) Patients: Clinical Characteristics, Genomics, and Survival
Authors: Hely Ollila, Amina Tidjani, Jennifer Sauter, Soo-Ryum Yang, Charles Simone, Michael Offin, Prasad Adusumilli
Read the Full Article on JCO Precision Oncology
More posts about Memorial Sloan Kettering Cancer Center.